C4 Therapeutics sets cemsidomide trial timelines through 2028

Go back to C4 Therapeutics sets cemsidomide trial timelines through 2028
Cache Capital Corp. (NASDAQ: CCCC) Delayed: 3.93 +0.03 (0.77%)
Previous Close $3.90    52 Week High $0.30 
Open $3.93    52 Week Low $0.30 
Day High $3.97    P/E N/A 
Day Low $3.89    EPS $0.00 
Volume 546,700